Total Payments
$8,694
2024 Payments
$2,635
Companies
26
Transactions
501
Medicare Patients
3,974
Medicare Billing
$223,093
Payment Breakdown by Category
Food & Beverage$8,396 (96.6%)
Education$298.09 (3.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,396 | 498 | 96.6% |
| Education | $298.09 | 3 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,016 | 113 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,190 | 83 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,040 | 64 | $0 (2024) |
| Dermavant Sciences, Inc. | $779.49 | 28 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $593.43 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $491.51 | 41 | $0 (2024) |
| PFIZER INC. | $426.79 | 34 | $0 (2024) |
| Incyte Corporation | $401.94 | 26 | $0 (2024) |
| Lilly USA, LLC | $281.33 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $266.24 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,635 | 133 | ABBVIE INC. ($553.19) |
| 2023 | $2,720 | 153 | ABBVIE INC. ($495.96) |
| 2022 | $1,985 | 124 | ABBVIE INC. ($598.32) |
| 2021 | $1,355 | 91 | AbbVie Inc. ($368.11) |
All Payment Transactions
501 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $129.28 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Dermatology | ||||||
| 10/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: Dermatology | ||||||
| 10/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $9.65 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $109.24 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $38.09 | General |
| 10/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,156 | 2,525 | $515,306 | $65,736 |
| 2022 | 10 | 1,049 | 2,291 | $392,000 | $60,514 |
| 2021 | 11 | 844 | 1,593 | $289,431 | $49,096 |
| 2020 | 10 | 925 | 1,642 | $315,463 | $47,747 |
Total Patients
3,974
Total Services
8,051
Medicare Billing
$223,093
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 247 | 348 | $91,524 | $16,139 | 17.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 171 | 201 | $75,978 | $10,943 | 14.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 193 | 267 | $81,069 | $7,884 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 117 | $43,524 | $7,449 | 17.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 159 | 1,232 | $103,488 | $4,458 | 4.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $22,278 | $4,178 | 18.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 75 | 75 | $24,075 | $4,137 | 17.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 30 | 39 | $28,638 | $3,572 | 12.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 66 | 112 | $22,960 | $3,360 | 14.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 44 | 45 | $18,855 | $3,050 | 16.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 17 | $2,508 | $545.50 | 21.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 25 | $408.25 | $19.61 | 4.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 235 | 332 | $62,589 | $15,855 | 25.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 179 | 209 | $59,947 | $10,984 | 18.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 177 | 244 | $74,086 | $7,015 | 9.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 88 | $24,042 | $6,389 | 26.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 89 | 89 | $25,902 | $4,599 | 17.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 142 | 1,121 | $82,819 | $4,312 | 5.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 63 | 112 | $17,328 | $3,422 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $11,252 | $2,937 | 26.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 26 | 31 | $22,764 | $2,840 | 12.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 32 | 33 | $11,272 | $2,161 | 19.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 192 | 252 | $47,507 | $12,762 | 26.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 152 | 162 | $46,466 | $9,185 | 19.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 80 | $21,856 | $5,613 | 25.7% |
About Erin Risco, NP
Erin Risco, NP is a Nurse Practitioner healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2013. The National Provider Identifier (NPI) number assigned to this provider is 1295172989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Erin Risco, NP has received a total of $8,694 in payments from pharmaceutical and medical device companies, with $2,635 received in 2024. These payments were reported across 501 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($8,396).
As a Medicare-enrolled provider, Risco has provided services to 3,974 Medicare beneficiaries, totaling 8,051 services with total Medicare billing of $223,093. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Mobile, AL
- Active Since 06/04/2013
- Last Updated 02/23/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1295172989
Products in Payments
- SKYRIZI (Biological) $959.03
- RINVOQ (Biological) $880.97
- VTAMA (Drug) $779.49
- DUPIXENT (Biological) $565.20
- COSENTYX (Biological) $481.58
- COSENTYX (Drug) $428.53
- EUCRISA (Drug) $406.78
- OPZELURA (Drug) $401.94
- TREMFYA (Drug) $354.02
- ILUMYA (Biological) $329.84
- TALTZ (Drug) $281.33
- Sotyktu (Drug) $250.97
- BLU-U (Medical Supply) $213.00
- Winlevi (Drug) $176.67
- Otezla (Drug) $166.48
- REMICADE (Biological) $164.99
- HUMIRA (Biological) $132.32
- Zoryve (Drug) $109.69
- LIBTAYO (Biological) $91.79
- Ilumya (Biological) $84.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Mobile
Ardie Pack-Mabien, Crnp, CRNP
Nurse Practitioner — Payments: $20,353
Nurse Practitioner $20,353
Wilma Baliem, Crnp, CRNP
Nurse Practitioner — Payments: $9,627
Nurse Practitioner $9,627
Brandi Clayton, Np-C, NP-C
Nurse Practitioner — Payments: $7,692
Nurse Practitioner $7,692
Hope Tindle
Nurse Practitioner — Payments: $7,611
Nurse Practitioner $7,611
Mrs. Chelsea Sigler
Nurse Practitioner — Payments: $5,581
Nurse Practitioner $5,581
Elise Split, Crnp, CRNP
Nurse Practitioner — Payments: $5,497
Nurse Practitioner $5,497